{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:35:45Z","timestamp":1788536145727,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Comput Assist Tomogr"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aimed to develop and assess the precision of a radiomics signature based on computed tomography imaging for predicting segmental chromosomal aberrations (SCAs) status at 1p36 and 11q23 in neuroblastoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Eighty-seven pediatric patients diagnosed with neuroblastoma and with confirmed genetic testing for SCAs status at 1p36 and 11q23 were enrolled and randomly stratified into a training set and a test set. Radiomics features were extracted from 3-phase computed tomography images and analyzed using various statistical methods. An optimal set of radiomics features was selected using a least absolute shrinkage and selection operator regression model to calculate the radiomics score for each patient. The radiomics signature was validated using receiver operating characteristic curves to obtain the area under the curve and 95% confidence interval (CI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eight radiomics features were carefully selected and used to compute the radiomics score, which demonstrated a statistically significant distinction between the SCAs and non-SCAs groups in both sets. The radiomics signature achieved an area under the curve of 0.869 (95% CI, 0.788\u20130.943) and 0.883 (95% CI, 0.753\u20130.978) in the training and test sets, respectively. The accuracy of the radiomics signature was 0.817 and 0.778 in the training and test sets, respectively. The Hosmer-Lemeshow test confirmed that the radiomics signature was well calibrated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Computed tomography\u2013based radiomics signature has the potential to predict SCAs at 1p36 and 11q23 in neuroblastoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rct.0000000000001564","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T01:01:45Z","timestamp":1701133305000},"page":"472-479","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Computed Tomography\u2013Based Radiomics Signature for Predicting Segmental Chromosomal Aberrations at 1p36 and 11q23 in Pediatric Neuroblastoma"],"prefix":"10.1097","volume":"48","author":[{"given":"Haoru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"bib1-20250802","doi-asserted-by":"crossref","first-page":"188805","DOI":"10.1016\/j.bbcan.2022.188805","article-title":"Tumoral heterogeneity in neuroblastoma","volume":"1877","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"bib2-20250802","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00441-017-2761-2","article-title":"Spontaneous regression of neuroblastoma","volume":"372","year":"2018","journal-title":"Cell Tissue Res"},{"key":"bib3-20250802","first-page":"1014","article-title":"Neuroblastoma: an updated review on biology and treatment","volume":"20","year":"2019","journal-title":"Curr Drug Metab"},{"key":"bib4-20250802","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-med-011514-023121","article-title":"Neuroblastoma: molecular pathogenesis and therapy","volume":"66","year":"2015","journal-title":"Annu Rev Med"},{"key":"bib5-20250802","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMoa052399","article-title":"Chromosome 1p and 11q deletions and outcome in neuroblastoma","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"bib6-20250802","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.3346\/jkms.2020.35.e82","article-title":"Clinical significance of segmental chromosomal aberrations in patients with neuroblastoma: first report in Korean population","volume":"35","year":"2020","journal-title":"J Korean Med Sci"},{"key":"bib7-20250802","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised neuroblastoma risk classification system: a report from the children's oncology group","volume":"39","year":"2021","journal-title":"J Clin Oncol"},{"key":"bib8-20250802","first-page":"68","article-title":"Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification","volume":"39","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"bib9-20250802","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2821-2","article-title":"Neuroblastoma: clinical and biological approach to risk stratification and treatment","volume":"372","year":"2018","journal-title":"Cell Tissue Res"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3389\/fonc.2020.01393","article-title":"Radiomics analysis of multiparametric MRI for the preoperative prediction of lymph node metastasis in cervical cancer","volume":"10","year":"2020","journal-title":"Front Oncol"},{"key":"bib11-20250802","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s00261-023-03924-y","article-title":"MRI-based nomograms and radiomics in presurgical prediction of extraprostatic extension in prostate cancer: a systematic review","volume":"48","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"bib12-20250802","article-title":"CT-based radiomics predicts the malignancy of pulmonary nodules: a systematic review and Meta-analysis","year":"2023","journal-title":"Acad Radiol"},{"key":"bib13-20250802","doi-asserted-by":"crossref","first-page":"e0185190","DOI":"10.1371\/journal.pone.0185190","article-title":"Radiogenomics of neuroblastomas: relationships between imaging phenotypes, tumor genomic profile and survival","volume":"12","year":"2017","journal-title":"PloS One"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"687884","DOI":"10.3389\/fonc.2021.687884","article-title":"CT-based radiomics signature with machine learning predicts MYCN amplification in pediatric abdominal neuroblastoma","volume":"11","year":"2021","journal-title":"Front Oncol"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"e29110","DOI":"10.1002\/pbc.29110","article-title":"Radiogenomics prediction for MYCN amplification in neuroblastoma: a hypothesis generating study","volume":"68","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00381-022-05534-3","article-title":"CT-based morphologic and radiomics features for the classification of MYCN gene amplification status in pediatric neuroblastoma","volume":"38","year":"2022","journal-title":"Childs Nerv Syst"},{"key":"bib17-20250802","doi-asserted-by":"crossref","first-page":"e30280","DOI":"10.1002\/pbc.30280","article-title":"Development and validation of a CT-based radiomics signature for identifying high-risk neuroblastomas under the revised children's oncology group classification system","volume":"70","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"bib18-20250802","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","year":"2006","journal-title":"Neuroimage"},{"key":"bib19-20250802","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","year":"2017","journal-title":"Cancer Res"},{"key":"bib20-20250802","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pcl.2014.09.015","article-title":"Neuroblastoma: paradigm for precision medicine","volume":"62","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"bib21-20250802","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1114>3.0.CO;2-R","article-title":"Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification","volume":"91","year":"2001","journal-title":"Int J Cancer"},{"key":"bib22-20250802","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.3390\/cancers13235897","article-title":"Chromosome imbalances in neuroblastoma-recent molecular insight into chromosome 1p-deletion, 2p-gain, and 11q-deletion identifies new friends and foes for the future","volume":"13","year":"2021","journal-title":"Cancers (Basel)"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/08880018.2017.1330375","article-title":"Neuroblastoma in children: update on clinicopathologic and genetic prognostic factors","volume":"34","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"bib24-20250802","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.jpedsurg.2011.09.005","article-title":"Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification","volume":"46","year":"2011","journal-title":"J Pediatr Surg"},{"key":"bib25-20250802","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-017-0686-8","article-title":"11q deletion in neuroblastoma: a review of biological and clinical implications","volume":"16","year":"2017","journal-title":"Mol Cancer"},{"key":"bib26-20250802","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in medical imaging-\u201chow-to\u201d guide and critical reflection","volume":"11","year":"2020","journal-title":"Insights Imaging"},{"key":"bib27-20250802","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1007\/s00330-020-07246-1","article-title":"Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification","volume":"31","year":"2021","journal-title":"Eur Radiol"},{"key":"bib28-20250802","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/RCT.0000000000001480","article-title":"Prediction of MYCN gene amplification in pediatric neuroblastomas: development of a deep learning-based tool for automatic tumor segmentation and comparative analysis of computed tomography-based radiomics features harmonization","volume":"47","year":"2023","journal-title":"J Comput Assist Tomogr"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T23:12:10Z","timestamp":1754176330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001564","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,27]]}}}